Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.390
-0.010 (-0.71%)
At close: Dec 5, 2025, 4:00 PM EST
1.410
+0.020 (1.44%)
After-hours: Dec 5, 2025, 7:05 PM EST
Zentalis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -149.32 | -165.84 | -292.19 | -236.81 | -158.73 | -117.84 | |
| Depreciation & Amortization | 0.9 | 1.29 | 1.39 | 1.43 | 0.54 | 0.16 | |
| Loss (Gain) From Sale of Assets | -0.63 | -0.09 | 0.41 | 0.06 | -49.92 | - | |
| Asset Writedown & Restructuring Costs | 4.89 | 3.74 | 20 | - | 8.8 | - | |
| Loss (Gain) From Sale of Investments | -2.12 | -13.23 | -13.16 | -3.73 | 0.91 | 0.56 | |
| Loss (Gain) on Equity Investments | - | - | 16.01 | 16.28 | 1.83 | - | |
| Stock-Based Compensation | 48.96 | 67.27 | 54.82 | 46.84 | 35.74 | 23.15 | |
| Other Operating Activities | -21.87 | -47.45 | -0.97 | -1.08 | -9.88 | -0.69 | |
| Change in Accounts Receivable | - | -5 | - | - | - | - | |
| Change in Accounts Payable | -19.15 | -18.02 | 10.92 | 15.53 | 13.96 | 14.31 | |
| Change in Other Net Operating Assets | 4.33 | 6.48 | -5.06 | -2.28 | 2.64 | -6.46 | |
| Operating Cash Flow | -134.01 | -170.86 | -207.82 | -163.75 | -154.09 | -86.83 | |
| Capital Expenditures | - | -0.22 | -0.58 | -2.55 | -6.11 | -0.76 | |
| Sale of Property, Plant & Equipment | 0.57 | 0.07 | - | - | - | - | |
| Divestitures | - | - | - | - | -14.32 | - | |
| Investment in Securities | 130.89 | 176.72 | -43.88 | -111.63 | 2.31 | -284.07 | |
| Investing Cash Flow | 131.46 | 176.56 | -44.46 | -114.18 | -18.12 | -284.83 | |
| Issuance of Common Stock | 0.3 | 0.35 | 237.3 | 261.04 | 179.67 | 327.79 | |
| Repurchase of Common Stock | - | -0.24 | - | - | -1.15 | - | |
| Other Financing Activities | - | - | - | - | - | 18.42 | |
| Financing Cash Flow | 0.3 | 0.11 | 237.3 | 261.04 | 178.52 | 360.44 | |
| Net Cash Flow | -2.25 | 5.81 | -14.98 | -16.89 | 6.31 | -11.22 | |
| Free Cash Flow | -134.01 | -171.08 | -208.41 | -166.3 | -160.2 | -87.58 | |
| Free Cash Flow Margin | -498.82% | -253.74% | - | - | - | - | |
| Free Cash Flow Per Share | -1.87 | -2.41 | -3.19 | -3.15 | -3.75 | -3.12 | |
| Cash Income Tax Paid | 0.36 | 0.36 | 0.14 | 0.01 | 0.02 | 0.02 | |
| Levered Free Cash Flow | -62.71 | -67.1 | -86.97 | -88.02 | -89.16 | -43.06 | |
| Unlevered Free Cash Flow | -62.71 | -67.1 | -86.97 | -88.02 | -89.16 | -43.06 | |
| Change in Working Capital | -14.82 | -16.54 | 5.86 | 13.25 | 16.61 | 7.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.